These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 8919425)

  • 1. Risperidone-induced neuroleptic malignant syndrome: a case report and review.
    Meterissian GB
    Can J Psychiatry; 1996 Feb; 41(1):52-4. PubMed ID: 8919425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atypical neuroleptic malignant syndrome associated with risperidone treatment in two adolescents.
    Zalsman G; Lewis R; Konas S; Loebstein O; Goldberg P; Burguillo F; Nahshoni E; Munitz H
    Int J Adolesc Med Health; 2004; 16(2):179-82. PubMed ID: 15266995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Neuroleptic malignant syndrome and atypical antipsychotics: a brief review].
    Khaldi S; Kornreich C; Choubani Z; Gourevitch R
    Encephale; 2008 Dec; 34(6):618-24. PubMed ID: 19081460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroleptic malignant syndrome with risperidone.
    Levin GM; Lazowick AL; Powell HS
    J Clin Psychopharmacol; 1996 Apr; 16(2):192-3. PubMed ID: 8690838
    [No Abstract]   [Full Text] [Related]  

  • 5. Risperidone and NMS?
    Murray S; Haller E
    Psychiatr Serv; 1995 Sep; 46(9):951. PubMed ID: 7583513
    [No Abstract]   [Full Text] [Related]  

  • 6. Neuroleptic malignant syndrome during a change from haloperidol to risperidone.
    Reeves RR; Mack JE; Torres RA
    Ann Pharmacother; 2001 Jun; 35(6):698-701. PubMed ID: 11408988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risperidone, neuroleptic malignant syndrome and probable dementia with Lewy bodies.
    Sechi G; Agnetti V; Masuri R; Deiana GA; Pugliatti M; Paulus KS; Rosati G
    Prog Neuropsychopharmacol Biol Psychiatry; 2000 Aug; 24(6):1043-51. PubMed ID: 11041543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risperidone-induced neuroleptic malignant syndrome.
    Sharma R; Trappler B; Ng YK; Leeman CP
    Ann Pharmacother; 1996; 30(7-8):775-8. PubMed ID: 8826559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Case report: Neuroleptic malignant syndrome and diagnostic difficulties].
    Khouri C; Planès S; Logerot S; Villier C; Mallaret M
    Encephale; 2016 Jun; 42(3):277-80. PubMed ID: 26923996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-dose vitamin E plus vitamin B6 treatment of risperidone-related neuroleptic malignant syndrome.
    Dursun SM; Oluboka OJ; Devarajan S; Kutcher SP
    J Psychopharmacol; 1998; 12(2):220-1. PubMed ID: 9694035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A case of neuroleptic malignant syndrome induced by risperidone in a schizophrenic woman.
    Gallelli L; Spagnuolo V; Palleria C; De Sarro G; Ferraro M
    Curr Drug Saf; 2009 May; 4(2):119-20. PubMed ID: 19442104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Case study. Risperidone-Induced neuroleptic malignant syndrome in an adolescent.
    Robb AS; Chang W; Lee HK; Cook MS
    J Child Adolesc Psychopharmacol; 2000; 10(4):327-30. PubMed ID: 11191694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potentiating effect of fluphenazine decanoate and risperidone on development of neuroleptic malignant syndrome.
    Liu PY; Wu PC; Chen CY; Chen YC
    Gen Hosp Psychiatry; 2011; 33(1):84.e5-7. PubMed ID: 21353143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A study of neuroleptic malignant syndrome in the presenium and senium].
    Suzuki I; Honma H; Watanabe N; Matsubara S; Koyama T
    Seishin Shinkeigaku Zasshi; 1998; 100(6):387-97. PubMed ID: 9745353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroleptic malignant syndrome and atypical antipsychotic drugs.
    Ananth J; Parameswaran S; Gunatilake S; Burgoyne K; Sidhom T
    J Clin Psychiatry; 2004 Apr; 65(4):464-70. PubMed ID: 15119907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroleptic malignant syndrome due to atypical neuroleptics: three episodes in one patient.
    Bottlender R; Jäger M; Hofschuster E; Dobmeier P; Möller HJ
    Pharmacopsychiatry; 2002 May; 35(3):119-21. PubMed ID: 12107858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Neuroleptic malignant syndrome in users of risperidone].
    Gerritsen AA; de Jonghe-Rouleau AP; Stienstra-Liem LH
    Ned Tijdschr Geneeskd; 2004 Sep; 148(37):1801-4. PubMed ID: 15495506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroleptic malignant syndrome with risperidone.
    Gleason PP; Conigliaro RL
    Pharmacotherapy; 1997; 17(3):617-21. PubMed ID: 9165568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinguishing neuroleptic malignant syndrome (NMS) from NMS-like acute medical illnesses: a study of 34 cases.
    Sewell DD; Jeste DV
    J Neuropsychiatry Clin Neurosci; 1992; 4(3):265-9. PubMed ID: 1354002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antipsychotics leading to neuroleptic malignant syndrome in pregnancy.
    Ghaffari N; Dossett E; Lee RH; Aghajanian P
    Obstet Gynecol; 2012 Feb; 119(2 Pt 2):436-438. PubMed ID: 22270430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.